Managers / Q1 2022 · view latest →
Saraza Management, LP
CIK 0001894188 · 125 EAST 56TH STREET, 28TH FLOOR, NEW YORK, NY, 10022 · 646-860-0181
Summary
Saraza Management, LP reported $891M in U.S.-listed holdings across 4 positions for Q1 2022.
The portfolio is heavily concentrated: IFF alone accounts for 65.9% of reported value.
Compared with Q4 2021, the fund opened 0 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.0% · $829M
- Other · 7.0% · $63M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CNH INDL N V | SOLD OUT | −2.15M | 0 | −$42M | $0 |
| IRTCIRHYTHM TECHNOLOGIES INC | ADDED | +210.0K | 1.01M | +$65M | $159M |
| IFFINTERNATIONAL FLAVORS&FRAGRA | TRIMMED | −780.0K | 4.47M | −$204M | $587M |
| COLFAX CORP | TRIMMED | −200.0K | 1.57M | −$19M | $63M |
| BBWIBATH & BODY WORKS INC | HELD | −50.0K | 1.73M | −$41M | $82M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IFFINTERNATIONAL FLAVORS&FRAGRAhistory → | COM | 65.87% | $587M | 4.47M |
| 2 | IRTCIRHYTHM TECHNOLOGIES INChistory → | COM | 17.85% | $159M | 1.01M |
| 3 | BBWIBATH & BODY WORKS INChistory → | COM | 9.25% | $82M | 1.73M |
| 4 | COLFAX CORP | COM | 7.03% | $63M | 1.57M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $239M | 20 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $259M | 15 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $281M | 14 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $414M | 18 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $335M | 22 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $359M | 17 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | Under review | 17 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | Under review | 13 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $435M | 17 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | Under review | 15 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 11 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $604M | 9 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $756M | 8 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $662M | 5 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $788M | 3 | Jul 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $891M | 4 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.1B | 5 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.